The results of differential gene expression analysis show that in BC and OV cancers, there is a variation of gene expression profiles in patients with somatic or germline BRCA1/BRCA2 mutations, compared to patients without mutations, as well as between mutation types for the same gene. This evidence concerns the gene BRCA1 and breast cancer.